STOCK TITAN
  1. Home
  2. Sec-filings
  3. CACI
  4. [Form 4] CACI INTERNATIONAL INC /DE/ Insider Trading Activity

CACI Form 4: Director receives 338 RSUs with 2026 vesting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CACI International (CACI) reported an insider equity award. Director Debora A. Plunkett filed a Form 4 showing an acquisition of 338 Restricted Stock Units (RSUs) on October 16, 2025. The RSUs are scheduled to vest as follows: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Following the reported transaction, the filing lists 338 derivative securities beneficially owned with direct (D) ownership.

Positive

  • None.

Negative

  • None.
Insider Plunkett Debora A
Role Director
Type Security Shares Price Value
Grant/Award Restricted Stock Units 338 $0.00 --
Holdings After Transaction: Restricted Stock Units — 338 shares (Direct)
Footnotes (1)
  1. [object Object]
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Plunkett Debora A
(Last) (First) (Middle)
12021 SUNSET HILLS ROAD
(Street)
RESTON VA 20190
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CACI INTERNATIONAL INC /DE/ [ CACI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/16/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 10/16/2025 A 338 (1) (1) CACI Common Stock 338 (1) 338 D
Explanation of Responses:
1. On October 16, 2025, Ms. Plunkett was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
Remarks:
Debora A. Plunkett 10/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did CACI (CACI) disclose in this Form 4?

A director, Debora A. Plunkett, reported acquiring 338 RSUs on October 16, 2025.

How many RSUs were granted to the CACI director?

The filing shows a grant of 338 Restricted Stock Units.

What is the vesting schedule for the 338 CACI RSUs?

Vesting is 84 on Jan 14, 2026, 84 on Apr 14, 2026, 85 on Jul 13, 2026, and 85 on Oct 11, 2026.

What is the ownership form after the CACI RSU grant?

The filing lists direct (D) ownership of the derivative securities.

How many derivative securities are beneficially owned after the transaction?

The filing shows 338 derivative securities beneficially owned following the transaction.

Who is the reporting person in the CACI Form 4?

The reporting person is Debora A. Plunkett, a Director of CACI International.